A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia

Clinical trial NCT00650871 · COMPLETED

Trial details

NCT number: NCT00650871
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sleep Initiation and Maintenance Disorders

Start date: 2004-07-30
Primary completion: 2005-08-30
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.